Symposium 8 Novel therapeutic strategy for AML

[SY8-3] Hedgehog inhibitor attenuates leukemia-initiation potential in acute myeloid leukemia

Yosuke Minami¹, Nobuaki Fukushima², Seiji Kakiuchi³, Hironobu Minami³, Hitoshi Kiyoi², Tomoki Naoe⁴ (1.Department of Hematol., National Cancer Center Hos. East, Japan, 2.Department of Hematol. and Oncol., Nagoya University Graduate School of Med., Japan, 3.Department of Oncol. and Hematol., Kobe University Graduate School of Med., Japan, 4.National Hospital Organization Nagoya Medical Center, Japan)

Professional Experience and Education:
1990-1996 Bachelor of M.D., Nagoya University School of Medicine
1996-1999 Resident / Clinical Staff of Department of Hematology, Komaki Municipal Hospital
1999-2003 Ph.D. course, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
2003-2008 Research Associate, Division of Hematology-Oncology, Moores University of California San Diego Cancer Center
2008-2013 Clinical Staff / Lecturer, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
2013-2017 Lecturer, Department of Transfusion Medicine and Cell Therapy, Kobe University Hospital
2017-present Chief, Department of Hematology, National Cancer Center Hospital East
Other activities and Honors (selected):
2007 Scholarship & Plenary Speech, Keystone Symposia
2009 Scholarship & Plenary Speech, Gordon Research Conferences
2015 The 57th ASH annual meeting, program committee member and moderator
present JALSG: CML212 committee vice-PI, STIM213 committee, GML213 committee
present PMDA (Pharmaceuticals and Medical Devise Agency): medical expert adviser